The impact of left ventricle assist device on circulating endothelial microparticles - Pilot study

Neuroendocrinology Letters

Volumn 33, Issue SUPPL. 2, 2012, Pages 68-72

  Pitha, Jan ^a   Dorazilova, Zora ^a   Melenovsky, Vojtech ^a   Kralova Lesna, Ivana ^a   Stavek, Petr ^a   Stepankova, Jitka ^a   Urban, Marian ^a   Maly, Jiri ^a   Netuka, Ivan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Circulating endothelial microparticles; Endothelial dysfunction; Heart failure; Non pulsatile flow; Ventricle assist device

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; ENDOTHELIAL MICROPARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MALE; PILOT STUDY; PROSPECTIVE STUDY; VALVULAR HEART DISEASE;

EID: 84871076697     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Amabile N, Boulanger CM (2011). Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability? Eur Heart J. 32: 1958-1960.
2. Boulanger CM (2010). Microparticles, vascular function and hypertension. Curr Opin Nephrol Hypertens. 19: 177-180.
3. Brodsky SV, Satoskar A, Nadasdy T (2012). Endothelial microparticles in transplant patients - great potential but a long way to go. Front Biosci (Elite Ed). 1: 876-888.
4. Bulut D, Becker V, Mügge A (2011). Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can J Physiol Pharmacol. 89: 239-244.
5. Burger D, Touyz RM (2012). Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 6: 85-99.
6. Chironi GN, Simon A, Boulanger CM, Dignat-George F, Hugel B, Megnien JL, et al (2010). Circulating microparticles may influence early carotid artery remodeling. J Hypertens. 28: 789-796.
7. Chiu JJ, Chien S (2011). Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 91: 327-387.
8. Coyle LA, Ising MS, Gallagher C, Bhat G, Kurien S, Sobieski MA, et al (2010). Destination therapy: one-year outcomes in patients with a body mass index greater than 30. Artif Organs. 34: 93-97.
9. Dignat-George F, Boulanger CM (2011). The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 31: 27-33.
10. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, et al (2012a). Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 59: 26-36.
11. nd Annual Meeting and Scientific Sessions, April 18-21, 2012, Prague, Czech Republic, pp. 263-264.
12. Huang B, Cheng Y, Xie Q, Lin G, Wu Y, Feng Y, et al (2012). Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. Clin Cardiol. 35: 125-130.
13. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, et al (2012). Long term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? J Thorac Cardiovasc Surg. 144: 584-603.
14. Long JW (2008). Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg. 135: 1353-1360.
15. Lund LH, Matthews J, Aaronson K (2010). Patient selection for left ventricular assist devices. Eur J Heart Fail. 12: 434-443.
16. Milla F, Pinney SP, Anyanwu AC (2012). Indications for heart transplantation in current era of left ventricular assist devices. Mt Sinai J Med. 79: 305-316.
17. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al (2007). Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 357: 885-896. (Pubitemid 47347322)
18. Mobarrez F, Egberg N, Antovic J, Bröijersen A, Jörneskog G, Wallén H (2012). Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res. 129: 95-97.
19. Morel O, Morel N, Jesel L, Freyssinet JM, Toti F (2011). Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol. 33: 469-486.
20. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al. (2009). Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 54: 312-321.
21. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, et al. (2012). Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail.5: 241-248.
22. Pirbodaghi T, Axiak S, Weber A, Gempp T, Vandenberghe S (2012a). Pulsatile control of rotary blood pumps: Does the modulation waveform matter? J Thorac Cardiovasc Surg. 144: 970-977.
23. Pirbodaghi T (2012). We always need a pulse, or do we? J Cardiovasc Transl Res. Aug 18. [Epub ahead of print].
24. Potapov EV, Stepanenko A, Krabatsch T, Hetzer R (2011). Managing long-term complications of left ventricular assist device therapy. Curr Opin Cardiol. 26: 237-244.
25. Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, et al (2012). High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles - brief report. Arterioscler Thromb Vasc Biol. 32: 1054-1058.
26. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al (2010). Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 55: 1826-1834.
27. Rose AG, Park SJ (2005). Pathology in patients with ventricular assist devices: a study of 21 autopsies, 24 ventricular apical core biopsies and 24 explanted hearts. Cardiovasc Pathol. 14: 19-23. (Pubitemid 40248428)
28. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al (2009). Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 361: 2241-2251.
29. Slavík L (2010). Mikropartikule. [(Microparticles.) (In Czech)]. In vitro diagnostic, 16: 19-22.
30. Tramontano AF, O'Leary J, Black AD, Muniyappa R, Cutaia MV, El-Sherif N (2004). Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun. 320: 34-38. (Pubitemid 38781781)
31. Vafeiadou K, Weech M, Sharma V, Yaqoob P, Todd S, Williams CM, et al (2012). A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles. Br J Nutr. 107: 303-324.
32. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003). Microparticles in cardiovascular diseases. Cardiovasc Res. 59: 277-287. (Pubitemid 37272022)
33. Zieman SJ, Melenovsky V, Kass DA (2005). Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 25: 932-943. (Pubitemid 40627836)